The impact of using a partially randomised patient preference design when evaluating alternative managements for heavy menstrual bleeding - PubMed (original) (raw)
Clinical Trial
The impact of using a partially randomised patient preference design when evaluating alternative managements for heavy menstrual bleeding
K G Cooper et al. Br J Obstet Gynaecol. 1997 Dec.
Abstract
Objective: To identify the advantages and disadvantages of using a partially randomised patient preference design rather than a conventional randomised controlled design when evaluating alternative managements for heavy menstrual bleeding.
Design: Randomised controlled comparison of two clinical trial designs with subsequent follow up of the cohorts of women generated.
Participants: Women attending a general gynaecology clinic for the first time because of heavy menstrual bleeding.
Interventions: Partially randomised patient preference clinical trial design and conventional randomised controlled design.
Main outcome measures: Overall participation; participation in randomised clinical trial of medical management compared with transcervical surgical resection of the endometrium; prognostic characteristics (socio-demographic and Short Form 36) of clinical trial groups; outcomes (clinical and Short Form 36) of clinical trial groups.
Results: Overall, more women participated in the partially randomised patient preference design (130/135 vs 97/138; difference 27%, 95% CI 18% to 34%) but there was no difference in the numbers who agreed to be randomised (90/135 vs 97/138; difference-3%, 95% CI-15% to 7%). Women who chose medical management tended to have better general health, to be less restricted by their menstrual problems, with fewer having been previously treated by their general practitioner. Those who chose transcervical resection of the endometrium had all tried medical management and had higher bleeding scores. Follow up satisfactions and acceptability rates, and Short Form 36 scores were highest after transcervical resection of the endometrium, whether chosen or randomised. Acceptability and a desire to continue the same treatment was greater among those who chose medical management than those randomly allocated it.
Conclusions: Use of the partially randomised patient preference design did not affect recruitment to the randomised controlled trial suggesting that a conventionally designed trial would not be biased by motivational factors in this context. Data from the preference groups informed the generalisability of the results but did tend to confirm conclusions that anyway reasonably followed from the randomised controlled trial. The extra resource implications of using the partially randomised patient preference design were significant reflecting the additional 40% who participated and the extra analyses entailed.
Comment in
- Partially randomised patient preference trials.
Brocklehurst P. Brocklehurst P. Br J Obstet Gynaecol. 1997 Dec;104(12):1332-5. Br J Obstet Gynaecol. 1997. PMID: 9422008 No abstract available.
Similar articles
- Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes.
Cooper KG, Jack SA, Parkin DE, Grant AM. Cooper KG, et al. BJOG. 2001 Dec;108(12):1222-8. doi: 10.1111/j.1471-0528.2001.00275.x. BJOG. 2001. PMID: 11843383 Clinical Trial. - Two-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes.
Cooper KG, Parkin DE, Garratt AM, Grant AM. Cooper KG, et al. Br J Obstet Gynaecol. 1999 Mar;106(3):258-65. doi: 10.1111/j.1471-0528.1999.tb08240.x. Br J Obstet Gynaecol. 1999. PMID: 10426646 Clinical Trial. - Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery.
Sculpher MJ, Dwyer N, Byford S, Stirrat GM. Sculpher MJ, et al. Br J Obstet Gynaecol. 1996 Feb;103(2):142-9. doi: 10.1111/j.1471-0528.1996.tb09666.x. Br J Obstet Gynaecol. 1996. PMID: 8616131 Clinical Trial. - Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
Lethaby AE, Cooke I, Rees M. Lethaby AE, et al. Cochrane Database Syst Rev. 2000;(2):CD002126. doi: 10.1002/14651858.CD002126. Cochrane Database Syst Rev. 2000. PMID: 10796865 Updated. Review. - Endometrial resection / ablation techniques for heavy menstrual bleeding.
Lethaby A, Hickey M, Garry R, Penninx J. Lethaby A, et al. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD001501. doi: 10.1002/14651858.CD001501.pub3. Cochrane Database Syst Rev. 2009. PMID: 19821278 Updated. Review.
Cited by
- Does random treatment assignment cause harm to research participants?
Gross CP, Krumholz HM, Van Wye G, Emanuel EJ, Wendler D. Gross CP, et al. PLoS Med. 2006 Jun;3(6):e188. doi: 10.1371/journal.pmed.0030188. PLoS Med. 2006. PMID: 16719548 Free PMC article. - Systematic review to determine whether participation in a trial influences outcome.
Vist GE, Hagen KB, Devereaux PJ, Bryant D, Kristoffersen DT, Oxman AD. Vist GE, et al. BMJ. 2005 May 21;330(7501):1175. doi: 10.1136/bmj.330.7501.1175. BMJ. 2005. PMID: 15905256 Free PMC article. Review. - Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.
Hubacher D, Spector H, Monteith C, Chen PL, Hart C. Hubacher D, et al. Contraception. 2015 Mar;91(3):185-92. doi: 10.1016/j.contraception.2014.11.006. Epub 2014 Nov 15. Contraception. 2015. PMID: 25500324 Free PMC article. Clinical Trial. - Patient characteristics associated with participation in a practice-based study of depression in late life: the Spectrum study.
Gallo JJ, Bogner HR, Straton JB, Margo K, Lesho P, Rabins PV, Ford DE. Gallo JJ, et al. Int J Psychiatry Med. 2005;35(1):41-57. doi: 10.2190/K5B6-DD8E-TH1R-8GPT. Int J Psychiatry Med. 2005. PMID: 15977944 Free PMC article. Clinical Trial. - Outcomes for patients with the same disease treated inside and outside of randomized trials: a systematic review and meta-analysis.
Fernandes N, Bryant D, Griffith L, El-Rabbany M, Fernandes NM, Kean C, Marsh J, Mathur S, Moyer R, Reade CJ, Riva JJ, Somerville L, Bhatnagar N. Fernandes N, et al. CMAJ. 2014 Nov 4;186(16):E596-609. doi: 10.1503/cmaj.131693. Epub 2014 Sep 29. CMAJ. 2014. PMID: 25267774 Free PMC article. Review.